Thiolation and Cell-Penetrating Peptide Surface Functionalization of Porous Silicon Nanoparticles for Oral Delivery of Insulin

被引:93
作者
Shrestha, Neha [1 ]
Araujo, Francisca [1 ,2 ,3 ]
Shahbazi, Mohammad-Ali [1 ]
Makila, Ermei [1 ,4 ]
Gomes, Maria Joao [2 ,3 ]
Herranz-Blanco, Barbara [1 ]
Lindgren, Rici [4 ]
Granroth, Sari [5 ]
Kukk, Edwin [5 ]
Salonen, Jarno [4 ]
Hirvonen, Jouni [1 ]
Sarmento, Bruno [2 ,6 ]
Santos, Helder A. [1 ]
机构
[1] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem & Technol, FI-00014 Helsinki, Finland
[2] Univ Porto, I3S, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal
[3] Univ Porto, ICBAS, Rua Jorge Viterbo Ferreira, P-4050313 Oporto, Portugal
[4] Univ Turku, Dept Phys & Astron, Lab Ind Phys, FI-20014 Turku, Finland
[5] Univ Turku, Dept Phys & Astron, Phys Mat Lab, FI-20014 Turku, Finland
[6] Inst Invest Formacao Avancada Ciencias & Tecnol S, CESPU, Rua Cent Gandra 1317, P-4585116 Gandra Prd, Portugal
基金
欧洲研究理事会; 芬兰科学院;
关键词
INTESTINAL-ABSORPTION; DRUG-DELIVERY; MESOPOROUS SILICON; TRANSPORT; CHITOSAN; PERMEABILITY; MUCUS; NANOCARRIERS; PERMEATION; EPITHELIUM;
D O I
10.1002/adfm.201505252
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
During the last decades, advanced oral delivery systems to enhance the intestinal absorption of widely applicable proteins and peptides, particularly insulin, have been developed. Here, chitosan-conjugated undecylenic acid-modified thermally hydrocarbonized porous silicon nanoparticles (CSUn NPs) are used, which promote the mucoadhesion and cellular interactions, thus boosting the intestinal permeability of insulin. Then, to further potentiate the mucoadhesion and permeability enhancement of chitosan-modified NPs, the surface of the NPs is further modified with either L-cysteine (CYS-CSUn NPs) or a cell-penetrating peptide (CPP-CSUn NPs). CYS-CSUn and CPP-CSUn NPs show 17- and 12-fold increase in the apparent permeability of insulin across cellular intestinal cells, respectively, with significant enhancement in the cellular interactions. The insulin uptake mechanism pathways in intestinal cells from the developed NPs are also unraveled, which demonstrates major involvement of active transport process and electrostatic interactions, along with adsorptive and clathrin-mediated endocytic pathways. Moreover, after oral administration in diabetic rats, CYS-CSUn NPs show 1.86- and 2.03-fold increase in the relative bioavailability of insulin, as compared to empty NPs and oral insulin solution, respectively. In conclusion, this study presents L-cysteine modified CSUn NPs as a promising strategy with the ability to overcome the multiple barriers for oral delivery of insulin.
引用
收藏
页码:3405 / 3416
页数:12
相关论文
共 44 条
[1]   Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs [J].
Antunes, Filipa ;
Andrade, Fernanda ;
Araujo, Francisca ;
Ferreira, Domingos ;
Sarmento, Bruno .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 83 (03) :427-435
[2]   Microfluidic Assembly of a Multifunctional Tailorable Composite System Designed for Site Specific Combined Oral Delivery of Peptide Drugs [J].
Araujo, Francisca ;
Shrestha, Neha ;
Shahbazi, Mohammad-Ali ;
Liu, Dongfei ;
Herranz-Blanco, Barbara ;
Makila, Ermei M. ;
Salonen, Jarno J. ;
Hirvonen, Jouni T. ;
Granja, Pedro L. ;
Sarmento, Bruno ;
Santos, Helder A. .
ACS NANO, 2015, 9 (08) :8291-8302
[3]   The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium [J].
Araujo, Francisca ;
Shrestha, Neha ;
Shahbazi, Mohammed-Ali ;
Fonte, Pedro ;
Makila, Ermei M. ;
Salonen, Jarno J. ;
Hirvonen, Jouni T. ;
Granja, Pedro L. ;
Santos, Helder A. ;
Sarmento, Bruno .
BIOMATERIALS, 2014, 35 (33) :9199-9207
[4]   The safety of chitosan as a pharmaceutical excipient [J].
Baldrick, Paul .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2010, 56 (03) :290-299
[5]   Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: The effect of mucus on particle adsorption and transport [J].
Behrens, I ;
Pena, AIV ;
Alonso, MJ ;
Kissel, T .
PHARMACEUTICAL RESEARCH, 2002, 19 (08) :1185-1193
[6]   Thiolated chitosans [J].
Bernkop-Schnürch, A ;
Hornof, M ;
Guggi, D .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (01) :9-17
[7]   Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol [J].
Budhian, A ;
Siegel, SJ ;
Winey, KI .
JOURNAL OF MICROENCAPSULATION, 2005, 22 (07) :773-785
[8]   A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery [J].
Chen, Mei-Chin ;
Sonaje, Kiran ;
Chen, Ko-Jie ;
Sung, Hsing-Wen .
BIOMATERIALS, 2011, 32 (36) :9826-9838
[9]   Cell-Penetrating Peptides: Nanocarrier for Macromolecule Delivery in Living Cells [J].
Chugh, Archana ;
Eudes, Francois ;
Shim, Youn-Seb .
IUBMB LIFE, 2010, 62 (03) :183-193
[10]   The role of glutathione in the permeation enhancing effect of thiolated polymers [J].
Clausen, AE ;
Kast, CE ;
Bernkop-Schnürch, A .
PHARMACEUTICAL RESEARCH, 2002, 19 (05) :602-608